Sarki Abba Abdulkadir

This study identifies a bivalent binding site in MYC for small-molecule inhibitors and shows acetylation enhances inhibitor binding and oncogenic activity.

This study identifies four bladder cancer subtypes using transcriptomic and genomic data, finds one subtype responsive to BCG therapy, and develops a predictive model for recurrence risk.

This paper introduces HYDRAC, a polymer-based platform for targeted protein degradation, demonstrating its effectiveness in degrading MYC and KRAS in vitro and in vivo.